Conjunctivitis Therapeutics Markets, 2023 – Dominated by Akorn Incorporated, Allergan, Bausch Health, Novartis, and Santen Pharmaceutical – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Conjunctivitis Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The conjunctivitis therapeutics market will register a CAGR of over 8% by 2023. The ease of availability of antibiotic eye drops and ointments for the treatment of bacterial conjunctivitis and antibiotics for viral conjunctivitis is leading to an increase in the use of these therapeutics. The use of therapeutics is primarily to avoid the progression of t

Full Story →